FDA Clears Additional Flu Strains for Focus' MDx Assay | GenomeWeb

NEW YORK (GenomeWeb) – Quest Diagnostics business Focus Diagnostics today said that the US Food and Drug Administration has cleared eight additional influenza strains on the Simplexa Flu A/B & RSV Direct kit. 

The kit originally received 510(k) clearance in 2012. The additional flu strains cleared by the FDA are H7N9; H3N2 (both the Minnesota and Indiana strains; H1N1 (2011); H3N2 (the Ohio and Texas strains); and influenza B (Brisbane and Wisconsin strains). 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.